FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source...
life sciences
Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link
Weight-Loss Drug Wegovy Cuts Heart Attack, Stroke Risk by 20% in New Study
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
First Pill for Postpartum Depression Is Approved by FDA
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a...
CVS to Shed 5,000 Jobs in Cost-Cutting Push
The healthcare giant wants to trim corporate roles and spending on travel and its use of consultants. Source link
Biogen Buying Rare-Disease Drugmaker in $7.3 Billion Deal
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link
Eli Lilly to Acquire Obesity-Treatment Maker Versanis
Versanis shareholders could receive as much as $1.925 billion in cash, in an upfront payment and additional payments if certain...
In Battle With Microsoft, Google Bets on Medical AI Program to Crack Healthcare Industry
The search giant is fine-tuning chatbot technology via medical licensing exams. Source link
FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
Walgreens Lowers Financial Outlook Amid Weaker Retail Consumer Spending
The drugstore chain says it will step up cost-cutting measures and boost the long-term profitability of its healthcare business. Source...
Magic Mushrooms. LSD. Ketamine. The Drugs That Power Silicon Valley.
Listen to article(2 minutes)Elon Musk takes ketamine. Sergey Brin sometimes enjoys magic mushrooms. Executives at venture-capital firm Founders Fund, known...
Deadly Fungi Are Becoming More Common And We’re Running Out of Ways to Treat Them
Research suggests fungicides are weakening antifungals before they are up for approval. Source link
No More Shots: Pill Versions of Ozempic-Like Drugs Are Coming
Tablets could appeal to people who want to lose weight but despise needles, which injections like Ozempic require. Source link
Ozempic Maker Sues Spas and Clinics Selling Custom-Made Versions
Novo Nordisk accused the firms of false advertising, trademark infringement and unfair competition. Source link
After Illumina CEO’s Fall, Other Executives Are Expected to Take Hard Look at Deals
ShareListen(2 min) Source link
Illumina CEO Francis deSouza Resigns Amid Regulatory Hurdles, Proxy Fight
Activist investor Carl Icahn has signaled he wants former CEO Jay Flatley to return to gene-sequencing test maker. Source link
U.S. Chamber of Commerce Challenges Federal Government’s New Drug-Price Powers
The lawsuit is the second filed this week saying Medicare’s new negotiating authority is unconstitutional. Source link
Merck Challenges U.S. Government’s New Powers to Negotiate Drug Prices
The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights. Source link
Blood-Test Customers Mistakenly Told They May Have Cancer
Grail said its telemedicine vendor sent the inaccurate forms to 400 people because of a software glitch. Source link
FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage
HealthIn temporary move, Chinese drugmaker will be able to ship its cisplatin chemotherapy even though it hasn’t been FDA approved...
